On March 15, 2021, Boyarski et al.
On March 15, 2021, Boyarski et al.
Latest Updates: (01/18/2021)
Recurring symptoms lasting several months may require ongoing treatment in some patients who have experienced COVID-1
A new variant of the coronavirus that causes COVID-19 has been reported in the UK.
Increasing COVID-19 infections in children
Kidney transplant patients are vulnerable to severe COVID-19 infection due to chronic immunosuppression and underlyin
Healthcare Workers at Significant COVID-19 Risk
Plexision has been awarded a National Science Foundation (NSF) Phase 1 Small Business Innovation Research Grant.
Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation and immunological disorders. We also pioneer in R&D projects centered on integrating biomarker targets in all phases of drug development, from preclinical to post-marketing. Plexision’s technology can be adapted to
Our state-of-the-art laboratory is CLIA-certified and located in Pittsburgh, PA.